Literature DB >> 8262328

Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.

W G Stetler-Stevenson1, L A Liotta, D E Kleiner.   

Abstract

Tumor invasion and metastasis formation are major obstacles for successful cancer therapy. Metastasis is a complex multistep process that requires sequential interactions between the invasive cell and the extracellular matrix. A model system for tumor invasion of extracellular matrix barriers has been developed, and application of this model has facilitated our understanding of the molecular mechanisms of metastasis formation. This model consists of three steps: tumor cell adhesion, extracellular matrix proteolysis, and cell migration. The role of the matrix metalloprotease enzymes in tumor cell-mediated extracellular matrix proteolysis is well established. We review the functional domain structure of the matrix metalloprotease enzymes in general and specifically the interaction of metastasis-associated gelatinase A (72-kDa type IV collagenase) with the tissue inhibitor of metalloproteases-2 (TIMP-2). We also discuss the physiologic activation of the matrix metalloprotease enzymes and the specific cellular mechanism of action of gelatinase A.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262328     DOI: 10.1096/fasebj.7.15.8262328

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  112 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model.

Authors:  S D Webb; J A Sherratt; R G Fish
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 3.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 4.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

5.  The inhibitory effects of an antisense u-PAR vector on invasion of highly invasive human prostate carcinoma PC-3M cell subclones.

Authors:  Guoning Liao; Qingfen Li; Youmei Feng; Yaozu Deng; Zhuoya Li; Feili Gong; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

6.  The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Authors:  S Koochekpour; M Jeffers; P H Wang; C Gong; G A Taylor; L M Roessler; R Stearman; J R Vasselli; W G Stetler-Stevenson; W G Kaelin; W M Linehan; R D Klausner; J R Gnarra; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis.

Authors:  Lingli Xin; Qingxiang Hou; Q I Xiong; Xiaoping Ding
Journal:  Biomed Rep       Date:  2015-04-06

8.  Three-dimensional analysis of the substrate-dependent invasive behavior of a human lung tumor cell line with a confocal laser scanning microscope.

Authors:  A R Strohmaier; H Spring; E Spiess
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

9.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

10.  Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production.

Authors:  David T Chang; Jacqueline A Jones; Howard Meyerson; Erica Colton; Il Keun Kwon; Takehisa Matsuda; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.